baber/WOPTO huggingface dataset:
Patent AU-690949-B2 (AU)
Title: Local delivery of fibrinolysis enhancing agents
Inventor: DUNN RANDALL C
IPC: A61K35/12
Filed: 1994-12-09
Granted: 1998-05-07
Abstract: A method of preventing adhesions by topical administration of fibrinolysis enhancing agents is described. The method uses a topically applied polymeric matrix for delivery of a fibrinolyic agent, preferably urokinase, or tPA. In the most preferred embodiment, the matrix is extremely thin and is polymerized in situ to form a biodegradable polymeric matrix. The matrix provides controlled release of the agent over a period of time effective to prevent surgical adhesions and is biodegradable, usually within the same time frame. Examples demonstrate that the combination of the matrix and the urokinase or tPA is effective in preventing surgical adhesions.
Patent AU-552594-B2 (AU)
Title: Container closure cap with internal seal
Inventor: BENNETT JULIAN
IPC: B65D41/04
Filed: 1983-05-19
Granted: 1986-06-05
Abstract: A blank for a container closure, adapted for the formation of a gasket of synthetic plastics material in situ in the blank, includes an end wall (5), a continuous side wall (6) upstanding from the end wall (5) and enclosing an inner surface (10) of the end wall (5) and a plurality of spaced apart members (13) upstanding from the surface (10) within the boundary of the side wall (6). Each of the spaced apart members (13) has a retaining surface (14) obliquely inclined above the inner surface (10), whereby gasket material or precursor material (17) in the liquid state can be introduced into the closure blank and can flow at least partly around the members (13) and beneath said retaining surfaces (14) to be retained, upon solidification, in the closure blank.
Patent AU-680351-B2 (AU)
Title: Drilling and chipping tool
Inventor: MANSCHITZ ERWIN
IPC: B29B7/58
Filed: 1995-04-28
Granted: 1997-07-24
Abstract: The device has a housing (30) and an impact tool (28) with energizer piston (35) and at least a one-piece crankshaft (34) whose rotational axis runs at right angles to the impact direction of the impact tool. Between the drive motor (31) and impact tool is an axial stagger compensating element (33) which acts parallel to the impact direction of the impact tool. This element can be designed as a ball toothed coupling. The crankshaft has external gearing which interacts with the internal gearing of a coupling shaft. <IMAGE>
Patent AU-751517-B2 (AU)
Title: TGC method for inducting targeted somatic transgenesis
Inventor: EICHEL-STREIBER CHRISTOPH VON
IPC: C12N15/87
Filed: 1998-12-11
Granted: 2002-08-15
Abstract: The present invention concerns a TGC method for inducting targeted somatic transgenesis in an animal host, whereby bacteria with a foreign DNA integrated into an episomal vector release, under the control of eukaryotic regulatory elements forulterior transcription and expression, said foreign DNA in the case of infection of a foreign organism, organ, tissue, cell line or individual cells, causing transcription and expression of foreign DNA and/or foreign protein in said location.
Patent AU-730888-B2 (AU)
Title: Method of treating otitis media with uridine triphosphates and related compounds
Inventor: DRUTZ DAVID J
IPC: A61K31/7076
Filed: 1997-02-14
Granted: 2001-03-15
Abstract: A method of promoting drainage of congested middle ear fluid in a subject in need of such treatment is disclosed. The method comprises administering to the middle ear of the subject a uridine triphosphate such as uridine 5'-triphosphate (UTP), an analog of UTP, or any other analog, in an amount effective to promote drainage of congested middle ear fluid by hydrating mucous secretions in the middle ear or by stimulating ciliary beat frequency in the middle ear or eustachian tube. The method is useful for treating patients afflicted with otitis media and other middle ear diseases, otitis externa, and inner ear diseases including Ménière's Disease. Pharmaceutical formulations and methods of making the same are also disclosed. Methods of administering the same would include any liquid suspension (including nasal drops or spray), oral, inhaled by nebulization, topical, injected or suppository form.
Patent AU-748511-B2 (AU)
Title: Fungicides
Inventor: ATH NORMAN JOHN DE
IPC: A01N/
Filed: 1999-02-18
Granted: 2002-06-06
Abstract: The new compound, dimethy[3-(propoxycarbonylamino)propyl]ammonium O-ethylphosphonate, having fungicidal activity, its preparation, compositions comprising it and methods for its use in agriculture.
Patent AU-562187-B2 (AU)
Title: Lens cleaning fabric
Inventor: MENCKE ARLENE JUNE
IPC: G02C13/00
Filed: 1984-04-11
Granted: 1987-06-04
Abstract: An article and a method for cleaning a contact lens is disclosed, said method comprising providing a moistened non-woven fibrous web wherein the average fiber diameter is up to 50 microns, contacting and rubbing the lens with the fibrous web, and removing the lens from contact with the fibrous web.
Patent AU-712710-B2 (AU)
Title: Effervescent bisphosphonate formulation
Inventor: KATDARE ASHOK V
IPC: A61K47/32
Filed: 1997-05-13
Granted: 1999-11-11
Abstract: An effervescent formulation of alendronate contains an acid source, a carbonate source, a binder, a lubricant and, optionally, flavoring agents, colorants and sweeteners.
Patent AU-783316-B2 (AU)
Title: Method and apparatus for testing wireless communication channels
Inventor: FISCHEL SCOTT EDUARD
IPC: H04B17/00
Filed: 2001-01-10
Granted: 2005-10-13
Abstract: Techniques to test a wireless communication link. A traffic channel is tested via a test data service option (TDSO) that may be negotiated and connected similar to other services. Test parameters values may be proposed, accepted or rejected, and negotiated. Test data for a channel is generated based on a defined data pattern or a pseudo-random number generator. Sufficient test data may be generated based on the generator for a test interval, stored to a buffer, and thereafter retrieved from a particular section of the buffer to form data block(s) for each "active" frame. The traffic channel may be tested using discontinuous transmission. A two-state Markov chain determines whether or not to transmit test data for each frame. The average frame activity and average burst length are defined by selecting the probabilities for transitioning between the ON/OFF states of the Markov chain, which may be driven by a second generator.
Patent AU-755222-B2 (AU)
Title: Laser satellite communication systems
Inventor: BOZZAY JOSEPH MCALPIN
IPC: H04B10/118
Filed: 1998-12-10
Granted: 2002-12-05
Abstract: A laser satellite communication system which avoids atmospheric, wind and turbulence effects. A satellite or high altitude platform communication system includes an earth-orbiting satellite or high altitude platform carrying a laser communications receiver and an acknowledgement transmitter. A ground terminal having a laser communications transmitter which is caused to continuously transmit large data block signals. When one block of data signals is received at the satellite or platform, an acknowledgement signal is sent to earth from the satellite or platform. The ground terminal receives the acknowledgement signal and causes the ground terminal laser communication transmitter to continuously transmit the next succeeding large block data signals. This process is repeated until all of the data has been received by the earth-orbiting satellite or high altitude platform, whereby all of the large data block signals are received by the laser communication receiver through scintillation windows in the atmosphere.
Patent AU-713462-B2 (AU)
Title: Quickly disintegrable compression-molded materials and process for producing the same
Inventor: MURAKAMI TOSHIO
IPC: A61K47/10
Filed: 1997-07-10
Granted: 1999-12-02
Abstract: A quickly disintegratable compression-molded material characterized by comprising cellulose and erythritol.
Patent AU-705596-B2 (AU)
Title: Method for specifically detecting a coagulation factor V which has an increased stability toward activated protein C in the activated state
Inventor: KRAUS MICHAEL
IPC: G01N33/53
Filed: 1995-11-08
Granted: 1999-05-27
Abstract: A method for the qualitative detection and quantitative determn. of the stability of activated coagulation Factor V (F5) towards proteolytic degradation in a biological fluid sample comprises: (a) mixing the sample with a reagent (A), having a reduced content of functional F5 compared with normal human plasma; (b) adding a reagent (B) to activate the F5 in the sample; (c) adding a reagent (C) for proteolytic degradation of the activated F5 in the sample, and (d) adding reagents for determining the residual Factor Va (F5a) activity. The sample forms at most 20% (pref. ≤ 10%) of the total test vol.
Patent AU-574138-B2 (AU)
Title: Polyol composition with mould release agent
Inventor: BAGAGLIO GIANCARLO
IPC: C08G18/40
Filed: 1985-03-06
Granted: 1988-06-30
Abstract: Polyol compositions containing siloxane mould release agents, the latter being stabilised by a poly (ethyleneoxide) surfactant, useful in RIM processing of polyurethanes.
Patent AU-670436-B2 (AU)
Title: Track-bound vehicle unit consisting of at least two vehicles, with steered single set bogies
Inventor: ROSE ROLF-DIETER
IPC: B61F3/12
Filed: 1993-07-23
Granted: 1996-07-18
Abstract: In order to provide a coupling for the single-wheelset running gear unit (3, 4) for a vehicle system consisting of at least two track-guided vehicles with single-wheelset running gear units (3, 4), which coupling ensures the most accurate possible alignment of the single-wheelset running gear unit (3, 4) in the direction of the axis of the track under all travelling conditions, a self-steering device (self-steering elasticity e) is connected to an essentially rigid control device, which self-steering device permits self steering of the single-wheelset running gear unit (3, 4) in combination with the control. <IMAGE>
Patent AU-573844-B2 (AU)
Title: Membrane cleaning
Inventor: POTTINGER JOHN STEWARDSON
IPC: C25F1/08
Filed: 1985-06-13
Granted: 1988-06-23
Abstract: @ A porous electrically conducting filter, e.g. a membrane for filtration equipment, is cleaned by setting up an electrochemical cell comprising the membrane as a first electrode (usually the cathode), a second electrode, and an electrolyte capable of being electrolysed to a gaseous product at the first electrode. When a potential is applied across the cell, the gaseous product of electrolysis (e.g. in the form of microbubbles) cleans the surfaces of the membrane by forcing foulant material therefrom.The electrolyte is constituted by the liquid being filtered (with the possible addition of a salt to increase electrical conductivity, if necessary) thus enabling filter cleaning to be carried out in situ whilstthe liquid being filtered continues to be passed through the filter.
Patent AU-668744-B2 (AU)
Title: Microcellular radio network
Inventor: TAHKOKORPI MARKKU
IPC: H04Q11/04
Filed: 1993-06-30
Granted: 1996-05-16
Abstract: PCT No. PCT/FI93/00277 Sec. 371 Date Dec. 30, 1994 Sec. 102(e) Date Dec. 30, 1994 PCT Filed Jun. 30, 1993 PCT Pub. No. WO94/00959 PCT Pub. Date Jan. 6, 1994A microcellular radio network including a plurality of base transceiver stations and higher-level network elements, such as base station controllers and exchanges, and an SDH transmission network. The base transceiver stations and higher-level network elements are connected to nodes of the SDH network for dynamic establishment of digital transmission links. The network management of the SDH network is capable of dynamic allocation of transmission capacity of the transmission network to base transceiver stations or higher-level network elements according to their traffic load. The traffic load is determined on the basis of the number of transmission channels in use and those not in use, or on the basis of load information obtained from the network management of the radio network.
Patent AU-683215-B2 (AU)
Title: Prevention and treatment of peripheral neuropathy
Inventor: LEWIS MICHAEL E
IPC: A61K38/08
Filed: 1993-06-01
Granted: 1997-11-06
Abstract: The invention features a method of using insulin-like growth factor-I (IGF-I) or insulin-like growth factor-III (IGF-III) to prevent or treat peripheral neuropathy in a mammal.
Patent AU-756310-B2 (AU)
Title: A method and apparatus for manufacturing dissolvable tablets
Inventor: COFFEE RONALD ALAN
IPC: A61K9/20
Filed: 2000-05-05
Granted: 2003-01-09
Abstract: Consumable or dissolvable tablets are manufactured by: supplying a liquid containing a biodissolvable carrier to an outlet (41); establishing an electric field between the outlet (41) and a support surface (6) to cause liquid issuing from the outlet to form at least one fibre or fibrils of the biodissolvable carrier which fibre or fibrils deposit(s) onto the surface to form a fibre web or mat; separating the web or mat into a plurality of individual tablets; and incorporating at least one active ingredient on or in the tablets.
Patent AU-747718-B2 (AU)
Title: Hydraulically actuated tool for mounting and dismounting rolling mill neck bearings
Inventor: MARTINS ARMANDO S
IPC: F16C35/02
Filed: 2000-07-21
Granted: 2002-05-23
Abstract: A tool is disclosed for axially urging a bearing assembly (10) into and out of a seated position on the neck (18) of a roll in a rolling mill. The tool includes a piston (74) surrounded by a cylinder (66). The piston is removably fixed to the roll neck and is configured to internally subdivide the cylinder into first and second chambers (76a,76b). Fluid conduits (84a,84b) are arranged to alternatively pressurize the first and second chambers to alternatively shift the cylinder with respect to the thus fixed piston in opposite first and second directions. Movement of the cylinder in the first direction urges the bearing assembly into its seated position, and movement of the cylinder in the opposite second direction dislodges the bearing assembly from its seated position.  <IMAGE>
Patent AU-710877-B2 (AU)
Title: Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
Inventor: DAVIS ROGER J
IPC: C12Q1/68
Filed: 1996-01-26
Granted: 1999-09-30
Abstract: Disclosed are human mitogen-activated (MAP) kinase kinase isoforms (MKKs). MKKs mediate unique signal transduction pathways that activate human MAP kinases p38 and JNK, which result in activation of other factors, including activating transcription factor-2 (ATF2) and c-Jun. The pathways are activated by a number of factors, including cytokines and environmental stress. Methods are provided for identifying reagents that modulate MKK function or activity and for the use of such reagents in the treatment of MKK-mediated disorders.
Patent AU-622289-B2 (AU)
Title: Device in impact machines
Inventor: RODERT JORGEN ALF ROBERT
IPC: E21B17/00
Filed: 1990-03-06
Granted: 1992-04-02
Abstract: Device in impact machines. The device comprises a number of rods (6) provided with projections (51). The rods are journalled in a surrounding set of tubes (7) by means of elastic bushings (52,53) which are provided with grooves (57) though which said projections can be passed.
Patent AU-696572-B2 (AU)
Title: Method for treating tumors
Inventor: GRANGER GALE A
IPC: A61K35/14
Filed: 1996-03-15
Granted: 1998-09-10
Abstract: A method is provided for treatment of a mammalian patient having a tumor by administering to the patient allogenic donor lymphocytes that have been co-cultured in the presence of the patient-derived lymphocytes under conditions sufficient to alloactivate the donor lymphocytes. It is preferred that the donor lymphocytes be introduced intralesionally. This method is preferred for treatment of glioblastoma in humans.
Patent AU-703598-B2 (AU)
Title: Railway switch setting device
Inventor: DURCHSCHLAG GERALD
IPC: B61L5/04
Filed: 1996-05-02
Granted: 1999-03-25
Abstract: PCT No. PCT/AT96/00087 Sec. 371 Date Feb. 9, 1998 Sec. 102(e) Date Feb. 9, 1998 PCT Filed May 2, 1996 PCT Pub. No. WO96/34786 PCT Pub. Date Nov. 7, 1996A device for setting railway switches includes a plurality of interlinked hydraulic switching devices (6) connected to a separate reversible hydraulic drive unit in a manner offset in the longitudinal direction of the rails, wherein the working volumes of the hydraulic cylinder piston aggregates (6) are connected to driving movement in same direction. The pistons (20) or plungers (11) include push-open valves (18) for travel limitation.
Patent AU-644358-B2 (AU)
Title: Coated perfume particles
Inventor: SCHMIDT DIANE GROB
IPC: A61K8/00
Filed: 1990-05-10
Granted: 1993-12-09
Abstract: Perfume particles comprise perfume dispersed within certain water-insoluble polymeric carrier materials and encapsulated in a protective shell by coating with a friable coating material. The coated particles allow for preservation and protection of perfumes which are susceptible to degradation or loss in storage and in harsh cleaning conditions. In use, the surface coating fractures and the underlying carrier/perfume particles efficiently deliver a large variety of perfume types to fabrics or other surfaces.
Patent AU-526447-B2 (AU)
Title: Preparation of oxyphosphate cathode
Inventor: LECERF ANDRE
IPC: C01B25/37
Filed: 1980-02-14
Granted: 1983-01-13
Abstract: The invention relates to a positive active material for an electric cell with a non-aqueous electrolyte. Said active material is constituted by an oxyphosphate whose formula is CunOp(PO4)2,n being an integer greater than 3 and lower than or equal to 6 and p being equal to n-3. Application to lithium primary cells.
Patent AU-705193-B2 (AU)
Title: Novel dipeptide compound or pharmaceutically acceptable salt thereof and medical use thereof
Inventor: KATO RYOHEI
IPC: C07D263/06
Filed: 1996-06-28
Granted: 1999-05-20
Abstract: The present invention provides a novel dipeptide compound or pharmaceutically acceptable salt thereof which exhibits an excellent HIV protease inhibitory activity and an excellent bioavailability from digestive tracts, and an anti-AIDS agent comprising said dipeptide compound as an effective ingredient. <CHEM> (wherein R1 represents 5-membered or 6-membered monocyclic hydrocarbon group or heterocyclic group wherein more than one carbon atom of said monocyclic hydrocarbon group is substituted with hetero atom. X represents methylene group (-CH2-), chloromethylene group(-CH(Cl)-), oxygen atom sulfur atom or sulfonyl group (-SO2-). R21 and R22 each represents hydrogen atom or aliphatic hydrocarbon group having 1-6 carbons. R3 represents aliphatic hydrocarbon group or monovalent group derived from aromatic monocyclic hydrocarbon having 1-6 carbons.)
Patent AU-754935-B2 (AU)
Title: Monoclonal antibodies against S100
Inventor: NILSSON OLLE
IPC: G01N33/53
Filed: 1999-08-27
Granted: 2002-11-28
Abstract: The present invention relates to novel monoclonal antibodies against the calcium binding protein S100, the use of these antibodies for the development of immunoassays for specific determination of total S100 or the different isoforms of S100 in serum, plasma, cerebrospinal fluid and other body fluids.
Patent AU-774804-B2 (AU)
Title: Support for holding open a bag
Inventor: HARVEY PETER KEVIN
IPC: B65B67/12
Filed: 2000-07-21
Granted: 2004-07-08
Abstract: The invention relates to a support for holding open a bag, in particular a plastic material rubbish bag. The support comprises a hoop and a plurality of clips spaced equidistantly around the hoop. The hoop defines an opening through which the open bag may be inserted with the opening of the bag being clipped to the clips. The hoop thereby supports the bag so that the bag hangs through the opening when the hoop is raised. The hoop has a circular cross-section, with each clip being spring-biased to conform to the hoop, so that the bag is pinched between the clip and the hoop. When the bag hangs from the support, the weight of the bag bears on each clip to pinch the bag tighter in each clip.
Patent AU-652540-B2 (AU)
Title: T cell receptor peptides as therapeutics for autoimmune and malignant disease
Inventor: VANDENBARK ARTHUR ALLEN
IPC: C07K16/28
Filed: 1990-07-19
Granted: 1994-09-01
Abstract: Peptides and pharmaceutical compositions comprising immunogenic peptides of a marker T cell receptor (TCR) characteristic of an immune-related disease, capable of preventing, suppressing, or treating the disease, are disclosed. In a preferred embodiment, the amino acid sequence of the peptide corresponds to at least part of a complementary determining region (CDR) or a hypervariable region of the TCR. Antibodies and/or T cells immunologically reactive to the TCR peptide capable of preventing, suppressing, or treating an immune-related disease by passive transfer are also disclosed.
Patent AU-707965-B2 (AU)
Title: Dispenser for a liquid medium consisting of two components
Inventor: BRUGGER GERHARD
IPC: B65D83/14
Filed: 1996-07-24
Granted: 1999-07-22
Abstract: The dispenser mixes two constituents issuing from separate storage containers. It incorporates an adjustable mixer (6) whose inlets (7,8) are joined to the outlets (9,10) of the reception parts (2,3) and whose outlet (11) is connected to the dispenser nozzle (13). The outlet of the mixer is joined to the dispenser nozzle by an extraction pump (12). The container (1) is a tube whose interior is divided into two chambers by a membrane (5).
Patent AU-647408-B2 (AU)
Title: Cystic fibrosis gene
Inventor: TSUI LAP-CHEE
IPC: C12N1/15
Filed: 1990-08-20
Granted: 1994-03-24
Abstract: A purified RNA molecule comprises an RNA sequence corresponding to a DNA molecule comprising an intronless DNA sequence selected from:  (a) DNA sequences which correspond to the DNA sequence of Figure 1 from amino acid residue position 1 to position 1480; (b) DNA sequences encoding normal CFTR polypeptide having the sequence according to Figure 1 for amino acid residue positions from 1 to 1480; (c) DNA sequences which correspond to a fragment of the sequence of Figure 1 including at least 16 sequential nucleotides between amino acid residue positions 1 and 1480; (d) DNA sequences which comprise at least 16 nucleotides and encode a fragment of the amino acid sequence of Figure 1; and (e) DNA sequences encoding an epitope encoded by at least 18 sequential nucleotides in the sequence of Figure 1 between amino acid residue positions I and 1480.  <??>Similar RNA molecules are also disclosed, as are nucleic acid probes and polypeptides based on the RNA sequences. <??>A method of screening for cystic fibrosis includes use of the nucleotide probes described.
Patent AU-663040-B2 (AU)
Title: Melting furnace with gas injection
Inventor: PERRIN NICOLAS
IPC: F27D3/16
Filed: 1994-05-26
Granted: 1995-09-21
Abstract: A furnace comprises a space overlying a charge into which space opens at least one oxygenated gas injector passing through the periphery of the furnace to deliver within this space a jet of gas that is nonradial relative to a vertical axis of the space. Each injector comprises a) a head (14) disposed within the thickness of the wall (1) of the furnace and having a gas passage having an axis (11) inclined at a predetermined angle ( alpha ) to an axis (15) that is substantially radial relative to the vertical axis of the space overlying the charge and b) a substantially cylindrical body (16) prolonging the head and the gas passage within the furnace along this substantially radial axis (15), itself substantially perpendicular to the wall (1) through which it passes. The injector is useful in an electric furnace for melting scrap for the production of steel.